Serum low-density lipoprotein and heart rate related to the effectiveness in the treatment of angina pectoris with two similar Chinese medicine herbal formulae

Chinese Journal of Integrative Medicine

Volumn 17, Issue 12, 2011, Pages 903-907

  Yan, Shi Yan ^a   Yao, Chen ^b   Ding, Xiao Rong ^a   Jiang, Miao ^a   Lu, Ai Ping ^a,c  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

^c SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Angina pectoris; Chinese medicine; Heart rate; Low density lipoprotein; Qi deficiency and blood stasis syndrome

Indexed keywords

CARDIOVASCULAR AGENT; CHINESE DRUG; GLYCERYL TRINITRATE; KANGXIN; LOW DENSITY LIPOPROTEIN; TONGXINLUO; UNCLASSIFIED DRUG; HERBACEOUS AGENT;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CHINESE MEDICINE; CHINESE MEDICINE SYNDROME OF QI DEFICIENCY AND BLOOD STASIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEART RATE; HEMATOLOGIC DISEASE; HEMOSTASIS; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; UNSPECIFIED SIDE EFFECT; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT; PHYSIOLOGY; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ADULT; AGED; ANGINA PECTORIS; DRUGS, CHINESE HERBAL; FEMALE; HEART RATE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PATIENT DROPOUTS; PLATELET COUNT; TREATMENT OUTCOME;

EID: 84859887577     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-011-0933-6     Document Type: Article

References (20)

1. Lu AP, Jia HW, Xiao C, Lu QP. Theory of traditional Chinese medicine and therapeutic method of diseases. World J Gastroenterol 2004;10:1854-1856.
2. Lu AP, Chen KJ. Integrative medicine in clinical practice: from pattern differentiation in traditional Chinese medicine to disease treatment. Chin J Integr Med 2009;15:152.
3. He Y, Lu A, Lu C, Zha Y, Yan X, Song Y, et al. Symptom combinations assessed in traditional Chinese medicine and its predictive role in ACR20 effectiveness response in rheumatoid arthritis. Am J Chin Med 2008;36:675-683.
4. Xiao JJ, Chen YH. Prevalence of cardiovascular diseases in China. Front Med China (Chin) 2010;4:16-20.
5. Zhang XH, Lu ZL, Liu L. Coronary heart disease in China. Heart 2008;94:1126-1131.
6. Bernard R, Corday E, Eliasch H, Gonin A, Hiait R, Nikolaeva LF, et al. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 1979;59:607-609
7. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients with Chronic Stable Angina). J Am Coll Cardiol 2003;41:159-168.
8. Chen W, Sun X, Wang WJ, Fu XD, Fu DY, Zhou JM, et al. Effects of Tongxinluo Capsule on cardiac ventricle remodeling after myocardial infarction: a multicentre clinical research. Nat Med J China (Chin) 2008;88:2271-2273.
9. Xu GC, Gao RL, Wu YL. Clinical study on Tongxinluo Capsule in treatment of patients with angina pectoris caused by coronary heart disease. Chin J Integr Tradit West Med (Chin) 1997;17:414-416.
10. Chen KJ, Liao JZ, Xiao ZX, eds. Resear ch on cardiocerebrovascular diseases. Shanghai: Shanghai Publishing Company of Science and Technology; 1998:318-319.
11. The 18th World Medical Assembly. Declaration of Helsinki. Helsinki, Finland, 1964.
12. State Food and Drug Administration of China. Good clinical practice. Beijing: State Food and Drug Administration of China; 1999.
13. Zheng GL, Wang SH. Clinical effect and mechanismn of Xuefu Zhuyu Capsule in treating unstable angina pectoris. Chin J Integr Tradit West Med (Chin) 2009;29:65-68.
14. Wang J, He QY, Li HX, Fang YT. Factor analysis of traditional Chinese medicine syndromes in 815 patients with unstable angina. J Chin Integr Med 2008;6:788-792.
15. He Y, Lu A, Zha Y, Tsang I. Differential effect on symptoms treated with traditional Chinese medicine and Western combination therapy in RA patients. Complement Ther Med 2008;16:206-211.
16. Gould AL, Davies GM, Alemao E, Yin DD, Cook Jr. Cholesterol reduction yields clinical benefits: meta-analysis including recent trials. Clin Ther 2007;29:778-794.
17. Horwich T. Low-density lipoprotein in the setting of congestive heart failure: is lower really better? Curr Atheroscler Rep 2009;11:343-349.
18. Liu JX, Shang XH, Wang G. Effect of Tongxinluo Capsule on experimental myocardial ischemia, arrhythmia and hyperlipidemia. Chin J Integr Tradit West Med (Chin) 1997;17:425-428.
19. Yang YJ, Zhao JJ, Meng L. Effect of Tongxinluo ultramicropulverization on myocardial post-reperfusion no-reflow in mini-swine model of acute myocardial infarction. Chin J Integr Tradit West Med (Chin) 2006;26:49-53
20. Chen WQ, Zhong L, Zhang L, Ji XP, Zhao YX, Zhang C, et al. Chinese medicine Tongxinluo significantly lowers serum lipid levels and stabilizes vulnerable plaques in a rabbit model. J Ethnopharmacol 2009;124:103-110.